Dorzox T Eye Drop medicine is used to reduce fluid pressure inside the eyes in patients suffering from intraocular hypertension.
Dorzox T Eye Drop is a combination medicine used for the treatment of increased eye pressure in patients suffering from open-angle glaucoma or ocular hypertension, conditions which may lead to eventual vision loss. Dorzox T Eye Drop medicine is not recommended for use in patients less than 2 years of age.
The drug should be avoided if you are allergic to any substance that is present in it, or suffer from kidney issues. Medical professional do not recommend Dorzox T Eye Drop to patients who are already using another type of carbonic anhydrase inhibitor.
Drug = Dorzolamide + Timolol
Strength = 2% + 0.5%
Manufacture = Cipla Inc.
Take Dorzox T Eye Drop in the dose and duration as advised by your doctor. Check the label for directions before use. Hold the dropper close to the eye without touching Dorzox T Eye Drop. Gently squeeze the dropper and place the medicine inside the lower eyelid. Wipe off extra liquid.
Dorzox T Eye Drop
Dorzox 2% Eye Drop
Blurred vision
Cataract
Headache
Increase in blood pressure
Infections
Dizziness
Stinging, burning, or discomfort in the eye
Sensitivity to light
Bitter taste
Upset stomach
Itching eyes
Redness or swelling of eyes
Watery eyes
Nausea
Dorzox T Eye Drop may be unsafe to use during pregnancy. Animal studies have shown adverse effects on the foetus, however, there are limited human studies. The benefits from use in pregnant women may be acceptable despite the risk. Please consult your doctor.Dorzox T Eye Drop helps lower high pressure in the eye and reduces the risk of vision loss.
Apply pressure on the corner of the eye (close to the nose) for about 1 minute, immediately after instilling the drop. Dorzox T Eye Drop minimizes the risk of side effects.
Dorzox T Eye Drop medicine is used to reduce fluid pressure inside the eyes in patients suffering from intraocular hypertension. Dorzox T Eye Drop medicine is used to reduce fluid pressure inside the eyes in patients suffering from open-angle glaucoma.
